Cleveland Biolabs Inc. (CBLI) Announces Departure Of Jean Viallet To Assume Oncology Development Leadership Role At Leading Biopharmaceutical
12/18/2013 1:44:34 PM
BUFFALO, N.Y., Dec. 18, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) today reported that Chief Development Officer, Jean Viallet, MD will leave the Company to assume an oncology global clinical research leadership role at Bristol-Myers Squibb, effective January 3, 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by